⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiophene SCHEMBL9373298 | 0.88 | CES2 (0.53) | — | |
| SCHEMBL2872059 | 0.82 | GSK3B (0.67) | — | |
| SCHEMBL1244072 | 0.80 | CES2 (0.73) | — | |
| SCHEMBL71972 | 0.78 | — | — | |
| SCHEMBL14624168 | 0.77 | GSK3B (0.63) | — | |
| SCHEMBL1455897 | 0.76 | — | — | |
| SCHEMBL17028614 | 0.76 | — | — | |
| SCHEMBL1476181 | 0.76 | — | — | |
| SCHEMBL24198806 | 0.76 | CES2 (0.59) | — | |
| SCHEMBL70702 | 0.76 | DAO (0.63) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 768 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119409712-A | Azafluoroboro fluorescent dye molecule with near infrared two-region absorption and preparation method and application thereof | 泰州职业技术学院 | 2025-02-11 | — | — | CN | claimed |
| CN-114478500-B | Coumarin two-photon initiator and synthesis method and application thereof | 浙江大学 | 2024-03-29 | — | — | CN | claimed |
| CN-117486872-A | Mechanical ball milling synthesis method of aminothiazole compound | 浙江工业大学 | 2024-02-02 | — | — | CN | claimed |
| CN-113201295-A | Release film with high residual adhesion rate and preparation method thereof | 佛山华韩卫生材料有限公司 | 2021-08-03 | — | — | CN | claimed |
| CN-113185531-A | Preparation method of photoinitiator for release film | 佛山华韩卫生材料有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-111171040-A | Dihydrofuropyran/pyridoindole derivatives and synthesis method thereof | 常州大学 | 2020-05-19 | — | — | CN | claimed |
| CN-104693167-A | Novel crystal form crystal of 1-(5-bromothiophene-2-yl)-3-(nitrobenzophenone)-2alkene-1-ketone and preparation method thereof | UNIV TIANJIN | 2015-06-10 | — | — | CN | claimed |
| US-6096124-A | Ink compositions | XEROX CORPORATION (US) | 2000-08-01 | — | — | US | claimed |
| EP-4731216-A1 | HETEROARYL-AMINE COMPOUNDS AND USE THEREOF AS HDAC6 INHIBITORS | Augustine Therapeutics (BE) | 2026-04-29 | — | — | EP | disclosed |
| US-12552757-B2 | NRF2-activating compound | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2026-02-17 | — | — | US | disclosed |
| US-20250382290-A1 | SALTS OF SOS1 INHIBITORS | Mirati Therapeutics, Inc. (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4650002-A1 | ANILINE-BASED MODULATORS OF THE NUCLEAR RECEPTOR TLX (NR2E1) | Ludwig-Maximilians-Universität (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-20250346585-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250270220-A1 | SOS1 INHIBITORS | Mirati Therapeutics, Inc. (US) | 2025-08-28 | — | — | US | disclosed |
| EP-0087953-A2 | Antibacterial 1-normon-2-yl-heterocyclic compounds | BEECHAM GROUP PLC (GB) | 1983-09-07 | — | — | EP | disclosed |
| US-4366321-A | Preparation of 2-halo-3-nitro-5-acyl thiophenes and intermediate compounds | EASTMAN KODAK COMPANY (US) | 1982-12-28 | — | — | US | disclosed |
| US-4105663-A | HYPOTENSIVE, BLOCKING AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-08-08 | — | — | US | disclosed |
| US-4093628-A | HYPOTENSIVE AGENTS, BLOCKING AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
| US-4082772-A | HYPOTENSIVE AGENTS, B-ADRENERGIC BLOCKING AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-04-04 | — | — | US | disclosed |
| US-4024156-A | Thiophene ethanolamines | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-05-17 | — | — | US | disclosed |